Margin of Safety Dashboard Finch Trades Research Notes My Profile Logout

Member Benefits Stocks We Cover

Articles Data Visualizations Newsletter Newsletter

What Is Solt DB?Public Benefit Our Lonely Team

Blockbuster Drug Products, Geographic Revenue Mix in 2023

A blockbuster drug product has at least $1 billion in annual revenue. However, American patients accounted for nearly 60% of total blockbuster sales in 2023.

By

Maxx Chatsko

Updated

August 18, 2024

Published

June 19, 2024

Learn Additional Business Context

Back to Data Visualizations

Members have access to additional investing context for the topic above.

Member Benefits

This topic was discussed in an article:

World's Bestselling Drugs Addicted to Broken U.S. Healthcare System

The global drug development industry boasted 152 blockbuster drugs that generated combined revenue of $511 billion in 2023. Over 58% percent ($298 billion) was generated from patients in the United States.

This topic can be explored through this external primary source:

This topic can be explored through this external primary source:

This topic can be explored through this external primary source:

ABOUT

What Is Solt DB?

Our Lonely Team

PUBLIC CONTENT

Data Visualizations

INVESTING

Member Benefits

Stocks We Cover

CONTACT

Questions?
Critiques?
Love letters?

Reach out here.

About Solt DB

Solt DB is an equities research firm and public benefit company exploring the business of biotech. For scientists, investors, and nerds of all stripes -- or feathers.

Yinz respect the finch n@. ©2026 Solt DB